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IMPROVING CONFIDENCE AND COMFORT IN DELIVERING 
 
 HEALTHCARE TO TRANSGENDER PATIENTS 
 
MICHELLE YOUNG 
ABSTRACT 
 As the population of transgender individuals continues to grow, it 
becomes increasingly important to expand the knowledge base for healthcare 
providers in the area of transgender health. Although transgender individuals may 
require specific needs that differ from patients who do not identify as transgender, 
healthcare visits for everyone are rooted in mutual trust and respect between 
provider and patient. Perhaps the most valuable tool a provider possesses is their 
ability to convince patients to accept care from them. Despite this, many 
transgender patients are not given the opportunity to receive care from 
knowledgeable and trustworthy providers. Transgender individuals often 
experience discrimination upon disclosure of their gender identity and are 
frequently the target of microaggressions in the form of inappropriate gender 
pronoun use by their providers.  
Transgender individuals are especially dependent upon primary care 
providers, as these professionals oversee the comprehensive healthcare needs of 
their patients and can make appropriate referrals to specialists for gender-
affirming therapies. Although many medical schools across the nation are 
implementing transgender health into their didactic and clinical curriculum, many 
current-day providers received their medical training devoid of education in 
		 vi 
transgender health. As such, these providers lack both confidence and comfort in 
completing healthcare visits with this population. 
 Physicians, nurse practitioners, and physician assistants can all serve as 
primary care providers and these professionals receive training that includes 
classroom education and clinical learning. Thus, the proposed study will include 
both a formal lecture on transgender health and a hands-on intervention with 
transgender actor patients. Acquisition of confidence and comfort will be assessed 
through pre- and post-intervention surveys. After completing this seminar and 
hands-on intervention in transgender health, it is predicted that primary care 
providers will have increased confidence and comfort in delivering care to 
transgender individuals.  
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INTRODUCTION 
Background 
The relationship between provider and patient has always been a 
fundamental aspect of healthcare, dating back to the first appearance of the 
Hippocratic Oath. Today, this relationship based on trust and understanding must 
continue to be upheld for all patients, including transgender individuals who often 
do not feel understood. For transgender individuals, their gender identity is 
incongruent with the sex they were assigned at birth. A person who is born female 
but identifies as male may consider themselves a transgender male, female to 
male (FTM), or simply may prefer the term male.1 A person who is born male but 
identifies as female may also refer to themselves as a transgender female, male to 
female (MTF), or female.1 Gender identity should be distinguished from sexual 
orientation, which refers to the gender a person is attracted to emotionally, 
physically, or romantically. Transgender individuals may be heterosexual, gay, 
lesbian, bisexual, pansexual, or asexual.1 
The ability to access healthcare and receive care from a knowledgeable 
and trusting provider is essential to the well-being of transgender individuals. 
Many transgender patients postpone, or even skip, healthcare visits. This is often 
due to prior encounters with inexperienced and uninformed providers, as well as 
negative reactions upon disclosure of their gender identity. Likewise, providers 
should be well-informed on transgender health and have the capacity to offer a 
welcoming environment in order to best serve this population of patients. 
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Knowing which transgender sensitive questions to ask, what language to use, and 
being able to perform the appropriate exam techniques and tests have proven to be 
both challenging and uncomfortable for providers in many specialties.2-
6	Transgender health is a multidisciplinary area and providers in all specialties 
should be prepared to deliver care to this population. Specifically, primary care 
providers, who are responsible for monitoring the overall healthcare needs of their 
patients, must be well-versed in the needs of transgender patients through both 
education and patient care experience.  
Recently, medical schools across the U.S. reported student improvement 
in knowledge and comfort with transgender health after implementing LGBT 
health into their curriculum.7-9 However, this recent progress in LGBT health 
education in medical schools has not impacted the current provider workforce 
and, thus, transgender patients continue to report poor healthcare experiences 
today. This gap between medical student education and current provider practice 
presents an opportunity for existing primary care providers to receive hands-on, 
educational interventions in transgender health.   
Statement of the Problem 
A lack of training in LGBT health in medical schools and residency 
programs has contributed to the development of underprepared providers for 
transgender patients.2-6 As a result, there is a lack of cultural competency and 
sensitivity among many practitioners. Transgender patients are required, at times, 
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to “out” their identity to their providers in order to receive the care they desire and 
need. Many report some level of discrimination in this process.10-12 
Although providers have access to clinical guidelines about transgender 
health, they appear to be unfamiliar and uncomfortable interacting with and caring 
for transgender patients.2-6 An educational patient-care experience may increase 
the understanding of transgender health among providers. Many curricula and 
lectures in school and beyond do include information on transgender health,7-9 but 
this information has never been followed up with direct interaction with 
transgender patients. Giving an educational seminar to healthcare providers that 
includes role playing with transgender actor patients could allow for increased 
comfort and improved provider-patient relationships among transgender patients 
and their primary care providers (PCPs).  
Hypothesis 
Primary care providers will be more confident and comfortable in delivering care 
to the transgender population after participation in a seminar about transgender 
health and completing a hands-on educational intervention with transgender 
patient actors.  
Objectives and specific aims 
A review of the literature has exposed gaps in provider knowledge and 
familiarity with transgender health. Only in recent years has there been an effort 
to expose medical students to more material on LGBT patients during school. 
However, this does not impact those currently in the healthcare workforce and 
	4 
transgender patients still report unfair treatment by their providers at healthcare 
visits.  
The goal of the proposed two-part educational intervention will be to 
effectively enhance the confidence and comfort level of primary care providers in 
their ability to diagnose, treat, and counsel transgender patients. Additionally, this 
proposal aims to increase the likelihood of completing a healthcare visit with a 
transgender patient using culturally competent language and fostering a safe 
environment for the transgender patient. For the hands-on intervention, 
individuals will be recruited to serve as transgender actor patients in an objective 
structured clinical examination (OSCE) for primary care providers. This study 
aims to: 
1. Establish a baseline status of the attitudes, confidence, and comfort 
among primary care providers in caring for transgender individuals. 
2. Measure changes in attitudes, confidence, and comfort among primary 
care providers in caring for transgender individuals after an 
educational seminar.  
3. Measure changes in attitudes, confidence, and comfort among primary 
care providers in caring for transgender individuals after an OSCE 
with transgender patient actors. 
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REVIEW OF THE LITERATURE 
Overview 
Using data from the CDC’s Behavioral Risk Factor Surveillance System, 
the Williams Institute approximates that 0.6% of the U.S. adult population 
identified as transgender in 2017, which corresponds to 1.4 million individuals.13 
The word transgender is a broad term that encompasses individuals who feel as 
though their gender identity does not match their assigned gender at birth.1 
Individuals whose gender identity is in alignment with their biological sex may be 
referred to as cisgender.1 The degree to which individuals express their gender 
identity with masculinity and femininity is known as gender expression.1  
The estimated 1.4 million transgender individuals in the U.S. represent a 
more diverse population racially and ethnically than that of the general U.S. 
population. Within the adult transgender population in the U.S. 55% identify as 
White, 21% as Latino or Hispanic, 16% as African American or Black, and 8% as 
other.13 As the population of transgender individuals increases, the number of 
transgender patients who are seeking gender-affirming medical and surgical 
treatment continues to rise. Thus, there is a heightened need for healthcare 
providers who can provide competent care to these individuals.14 
The first available medical article that focused on the trans population was 
published in the American Journal of Psychotherapy in 1954, titled 
“Transsexualism and transvestism as psychosomatic and somatopsychic 
syndromes”.15 Since that time, there has been a dramatic shift in attitude and 
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treatment approach to the transgender patient. The majority of research in this 
field was conducted in the last decade, however there remains a shortage of 
knowledge regarding transgender health.15 Potential reasons for this may include 
a lack of research looking into long-term outcomes and a lack of randomized 
control trials. In their paper, Wanta and Ugner state that only 11 out of 2,405 
trans-centric Medline articles reviewed from 1950 to 2016 were randomized 
control trials.15 Transgender health has also taken a back seat to investigations on 
LGBT health as a whole. In his research, Snyder found that of 21,728 LGBT-
centered articles published from 1950-2007, only 2.66% of these articles were 
transgender specific.16 
Given that few articles on transgender care existed before this decade and 
that a knowledge gap exists in transgender healthcare even with current research 
findings, many present-day providers likely received a medical education lacking 
transgender-specific content.15 In a study on healthcare experiences for 
transgender individuals, one provider who was interviewed stated, “I don’t think 
that my training was very good in this area [transgender care]. I think that there 
was one course that was an optional course that I took in my master’s program 
and the textbook was ‘compassionate treatment of gays and lesbians’ and nothing 
else”.17 It would seem that for some professionals, transgender education was 
non-existent.  
In a survey of 7,000 transgender patients across the U.S., 50% of 
respondents reported teaching their provider about matters pertaining to their own 
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health.18 Specifically, FTM transgender patients, those whose gender identity 
aligned with their gender expression, and those with private insurance were more 
likely to report an incidence of educating their providers on their own health.18 In 
their paper, Shires and Jaffe found that FTM transgender patients who achieved 
higher levels of education experienced an increased likelihood of discrimination.10 
The authors postulate that those with more education have an enhanced ability to 
recognize discrimination and may have increased confidence and knowledge 
about their health, leading to provider discomfort. Providers may view an 
informed and confident patient as difficult, resulting in subtle behavior changes. 
This is then perceived by the patient as discrimination.10 
Beyond the toll of discrimination during interactions with healthcare 
professionals, some transgender individuals withstand threats to their safety. 
Using a national survey of 1,711 FTM transgender individuals, Shires and Jaffe 
found that 41.8% of participants reported verbal harassment, unequal treatment, 
or physical assault during an office or in-hospital healthcare visit.10 However, in 
another study on LGBTQ healthcare use and experience, the authors found that 
84% of respondents denied any occurrences of unequal treatment or harassment.11 
Of the participants in the study, 92.3% reported that disclosing their LGBTQ 
identity to their provider had either a neutral or positive impact on their 
experience and 88.3% denied postponing or foregoing care due to fear of 
discrimination.11 This underlines an important feature of the LGBTQ acronym -- 
the LGB portion refers to sexual orientation. Although transgender individuals 
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may also identify as lesbian, gay, or bisexual, it is critical to differentiate between 
the disclosure of sexual orientation and gender identity. Of the 206 participants, 
90% identified as cisgender and did not report any experiences of gender identity 
disclosure.11 It is possible that there were fewer negative experiences with 
disclosure of sexual orientation than there were with disclosure of gender identity. 
The authors report that transgender participants were more likely than their 
cisgender counterparts to report episodes of harassment, negative outcomes after 
disclosure of identity, and postponing care due to fear.11 It is likely that their 
poorer experiences were overshadowed when grouped into the entire sample. It is 
noteworthy that all transgender participants in this survey were non-white, 
making it possible that their race and ethnicity were confounding factors in their 
adverse experiences.  
In a study by Rossman et al., the authors sought to discover individuals’ 
reasons for disclosing or not disclosing LGBTQ identity to providers.12 They used 
open-ended questions and coded these responses for common themes of 
disclosure. These themes included provider knowledge, communication, provider 
attitude, and patient expectations.12 It is notable that among LGBTQ participants 
who listed provider knowledge as a reason for disclosure, all respondents 
recounted episodes of provider familiarity with LGBTQ care in the realm of 
sexual health, pertaining to sexually transmitted infections and HIV.12 None of the 
LGBTQ study participants reported delivery of information from their providers 
that was specific to transgender care.12 
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Ross et. al conducted a series of interviews with transgender patients, their 
family members and friends, and their healthcare providers. They found that all 
transgender individuals who were interviewed reported both positive and negative 
experiences with healthcare providers.17 Notably, all transgender participants in 
this study were Caucasian. The privilege associated with race influences many 
experiences in life, including the delivery of healthcare. However, the poor 
healthcare experiences reported by these Caucasian participants demonstrate that 
the privilege of race is not the only contributing factor in healthcare experiences.17 
Barriers at the system-level that contributed to negative healthcare experiences 
were lack of provider knowledge, long wait times for approval of hormone 
therapy or gender-affirming surgical treatment, and scarce transgender healthcare 
organizations and infrastructure.17 The authors found that many transgender 
patients were able to overcome these barriers with local and individual factors in 
order to achieve a positive experience. These included use of support groups, 
family and friend support, and utilizing personal diligence to self-navigate the 
healthcare system.17 Actions by providers that were viewed as important 
contributors to positive experiences included normalizing the transgender identity, 
active listening, allowing the patient to be in control of their transition, and asking 
about support networks inside and outside the home.17 
When transgender patients are hesitant to disclose their identity to 
providers, it is often due to fear of negative reactions. In a nationwide survey of 
transgender individuals, 89.1% of respondents thought that it was important for 
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their primary care provider to know their gender identity and 82% believed that it 
was important for primary care providers to know the gender identity of all of 
their patients.19 If patients were told by providers that their gender identity was 
relevant to their healthcare, 89% of MTF and 80% of FTM transgender patients 
stated they would be more willing to disclose.19 Transgender females were more 
likely to disclose if they were guaranteed confidentiality and transgender males 
were more likely to disclose if they were told that all patients are asked about 
gender identity.19 From the transgender perspective, it appears that these 
individuals place importance upon gender identity disclosure, yet they are fearful 
of being transparent with their providers. However, some providers have offered a 
different perspective on the importance of transparency within the provider-
patient relationship. A survey of oncology providers in Florida revealed that 43% 
of respondents believed it was important to know the sexual orientation of their 
patients. Only 59% believed it was important to know the gender identity of their 
patients.6 Some of these providers believed that patients who wanted to disclose 
their identity would take it upon themselves to do so. These providers regarded 
questions about gender identity and sexual orientation as uncomfortable questions 
for their patients.6 Many providers neglect to ask patients about their gender 
identity and preferred gender pronouns. It is likely that healthcare visits frequently 
proceed without gathering all the necessary information from this population of 
patients or that they proceed with a discordance in priorities between the provider 
and patient. 
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The ability of providers to deliver care not related to gender identity is 
also ranked high in importance for transgender patients. Twenty-two transgender 
or gender non-conforming individuals were interviewed at a family medicine 
clinic in Minnesota and asked questions regarding their experiences with primary 
care. The goal of this study was to identify how primary care clinics can improve 
care for their transgender and gender-nonconforming patients. Many of the 
participants were able to identify and share details of their positive experiences 
with providers. Study participants recounted episodes where their provider asked 
about aspects of their gender identity but also spent time discussing other facets of 
their lives and additional physical and mental health concerns.20 As one 
participant stated, “I really appreciate when people can see me as a whole person. 
Like being trans is part of me, but I’m also a parent, and there’s a lot of other 
parts of me that come into play”.20 Other individuals chose to talk about the 
feeling of being part of the team, and working with the provider towards a shared 
goal. “It is gold that when I come in, we’re having a conversation as two people 
who have information about the issue in question. One from a medical perspective 
and one from actually living it, and they are equally valid”.20 Still, other 
participants valued knowing that multiple staff members in a clinic were 
knowledgeable on transgender health.20 It was reassuring for them that more than 
one healthcare provider could take care of them.  
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Provider Counseling and Gender-affirming Treatment   
Transgender patients must often be diagnosed with gender dysphoria, 
previously termed gender identity disorder, in order to receive many of the 
gender-affirming treatments available.18 It can be emotionally and 
psychologically difficult for many individuals to be labeled with a psychiatric 
disorder, as this contradicts the belief that gender variance is normal. As such, it is 
important for transgender individuals to receive adequate guidance and 
counseling from their providers as they navigate their transition. The transitioning 
process can involve medications and/or surgical interventions. Of 7,000 
transgender individuals surveyed nationally, only 75% received any counseling 
regarding their gender identity and among those who were started on medication 
to transition, only 89% were given counseling.18  
Before starting any new medication, it is important for patients to be 
knowledgeable on its administration and side effects. Sanchez et. al found that 
only 58% of their transgender female participants in New York City underwent 
medical evaluations before starting hormone therapy and 45% of respondents 
stated they were taking a medication that might potentially affect their hormone 
therapy.21 Of the respondents on hormone therapy, 23% reported gathering 
information about their medications from non-physician sources.21 Transgender 
females who received regular care from a provider were more likely to acquire 
hormone therapy and needles from a licensed provider. However, there are 
individuals who take hormone therapy and receive needles from sources other 
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than a licensed professional. These individuals may share needles for hormone 
administration with others, which carries a risk of HIV acquisition.21 
HIV Acquisition and Prevention 
In 2015, the percentage of new HIV diagnoses in the U.S. transgender 
population was estimated to exceed the percentage of new diagnoses in the 
general U.S. population by three-fold.22 An estimated 22-26% of transgender 
females in the U.S. are living with HIV and an estimated 56% of black 
transgender females are living with HIV.22 A study from 2013 found that the odds 
of having a positive HIV status were almost five times higher in the transgender 
veteran population than in non-transgender veterans.23  
In another study by Reback et al., the authors sought to compare health 
disparities among transgender women in 1998-1999 and 2015-2016 with the aim 
of identifying how these disparities had worsened and/or improved over this 
seventeen-year time period. Among the outcomes measured in this study were 
HIV acquisition and HIV risk behaviors.  Over 200 transgender females from Los 
Angeles were sampled during each time period. The first study sample of 
transgender women included moderate to high-risk individuals.24 Due to 
improvements in perception and acceptability of transgender individuals, the 
high-risk behaviors present among transgender females in 1998-1999 were likely 
less prevalent among transgender females in 2015-2016. Thus, the study authors 
deemed it necessary to incorporate new inclusion criteria for the second study 
sample.24 Only transgender females who reported alcohol use, illicit drug use, or 
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unprotected anal intercourse within the past six months were eligible for 
enrollment in 2015-2016.24 Without these inclusion criteria, it would be possible 
for the second study sample to include low-risk transgender women. A sample 
containing low-risk transgender women would not be comparable to the 1998-
1999 sample.24 This investigation showed that individuals from the most recent 
study were more likely to have unprotected anal intercourse than those from the 
earlier study. Of the respondents in 2015-2016, 32.1% reported this with their 
main sexual partner, 32.8% with casual partners, and 18.8% with exchange 
partners, individuals who exchange sex from these transgender females in a trade 
for something else.24 Although the samples during each time period were similar 
in regards to sociodemographic features, this was not a longitudinal study. Any 
changes between the two study samples in regards to alcohol use, illicit drug use, 
or HIV acquisition and risk behaviors may just reflect the presence of inclusion 
criteria. It is possible that these results do not represent true differences in health 
disparities across the seventeen-year time period.  
In 2012, the U.S. Food and Drug Administration approved Truvada, an 
antiretroviral medication also commonly known as pre-exposure prophylaxis 
(PrEP), for prevention of HIV acquisition.25 PrEP is an oral medication that is 
taken daily and is associated with a relative risk reduction in acquiring HIV.25 
PrEP is directed towards those groups most at-risk for acquiring HIV, men who 
have sex with men and transgender women. However, the accessibility, 
acceptability, and use of PrEP appears to differ between transgender females and 
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men who have sex with men. As transgender females do not identify as male, it is 
possible that many themes of HIV prevention targeted at men who have sex with 
men do not seem relevant to the transgender female population.  
Golub et al. explored the use and accessibility to PrEP among 30 
transgender females in San Francisco through focus groups and in-person 
interviews. Zero participants had ever taken PrEP before and none had ever heard 
their provider mention PrEP before.25 In fact, some participants expressed anger 
during their focus groups and interviews upon learning of this medication, as their 
providers had never presented this as an option. Many women noted that being 
able to obtain PrEP from a provider proficient in transgender health would be a 
necessity even before considering its use.25 When talking about her current 
provider, one participant stated, “…Any conversations surrounding [sex] ends up 
with a bit of discomfort on his part. So, I try to figure out…when I actually talk 
about my self-advocacy or my self-education on these types of things, why 
doesn’t he really know how to [explore these topics with me]?”.25 
As marginalized members of society, many transgender women in this 
study viewed PrEP as an agent that would further ostracize them and facilitate 
discrimination, possibly making it appear that they had already contracted HIV or 
engage in risky sexual behaviors. As one participant stated, “…We already have a 
bad rep when it comes to sex…I wouldn’t want to be seen as a whore because I’m 
picking this up. Not that people who do sex work are bad, but I am talking about 
the stigmatized version of a whore…”25	Other barriers to PrEP that were stressed 
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in these interviews included prioritizing sex work over attending additional 
appointments, adhering to a pill regimen, and possible interactions with hormone 
therapy.25 Although this study only included 30 participants, it took place in San 
Francisco where the largest PrEP clinic in the world was located at the time of the 
study.25 Transwomen have specific needs concerning PrEP that differ from those 
for men who have sex with men and healthcare providers need to recognize and 
be familiar with these needs.   
Substance Use and Mental Health  
In 2013, the prevalence of transgender veterans in the U.S. was 58 per 
100,000.23 A study conducted by Brown and Jones on veterans in the U.S. 
highlighted some important health disparities between transgender veterans and 
non-transgender veterans. The authors identified 5,135 transgender veterans 
between the years 1996 to 2013. The inclusion criteria required a diagnosis of one 
or more of the following: gender identity disorder, gender identity disorder not 
otherwise specified, transsexualism, or transvestic fetishism.23 Each transgender 
veteran was matched 1:3 with non-transgender veterans for comparison and the 
researchers coded their health records for diagnoses. The rate of alcohol abuse 
was found to be 32.19% among transgender veterans and 18.26% among non-
transgender veterans.23 Depression and major depression were documented in 
74.33% and 47.73% of transgender veterans, respectively, compared to 37.7% 
and 17.21% in non-transgender veterans.23 Prior suicide attempt or history of 
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suicidal ideation was documented in 19.36% of transgender veterans, compared 
with 4.55% of non-transgender veterans.23 
This study used documentation of clinical diagnoses for inclusion criteria. 
It is possible that transgender individuals who had symptoms of these psychiatric 
conditions were not yet clinically diagnosed and, thus, excluded. Additionally, the 
Veterans Health Alliance does not collect birth sex or gender identity 
information.23 The available information for this study only included sex at the 
time of enrollment. This makes it impossible to compare differences among the 
individuals who identify as transgender males, transgender females, or 
somewhere in between. For example, a transgender female and a transgender 
male could both be documented as a female with gender identity disorder within 
the Veterans Health Alliance. Although this article does not provide insight as to 
why these health disparities exist, it does show that transgender individuals do 
have higher incidences of serious mental illness, alcohol abuse, and suicidality 
than non-transgender individuals. 
Healthcare Maintenance  
Another area of health-related disparities in the transgender population is 
gender-based cancer screening. Brown and Jones documented in their study on 
U.S. veterans that some healthcare systems do not keep records of gender identity 
or birth sex. This can have severe consequences for some health screenings such 
as PAP tests, mammograms, and prostate exams, in which reminders need to be 
targeted to a specific population of patients.  
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Peitzmeier et al. found that FTM transgender individuals were 8.3 times 
more likely to have an inadequate PAP test compared with the non-transgender 
female population.26 FTM transgender patients were just as likely to follow-up 
with an inadequate test as non-transgender females but the time to follow-up was 
greater for transgender males.26 Reasons for these test inadequacies might be due 
to lack of knowledge on the part of the provider and/or awkwardness with the 
exam for both the patient and provider. One patient recounted his provider’s 
response during a speculum exam. “…the doctor is like, ‘I can’t find your cervix.’ 
And I said it was because I had a hysterectomy. He was, at first he was baffled. I 
don’t think he even questioned my gender or physiology, or he couldn’t find my 
cervix, and he just said, ‘Okay’”.27 
For some transgender males who have begun hormone therapy, it is 
thought that testosterone can induce changes to cervical epithelium, resulting in 
PAP test inadequacy and lower susceptibility to persistent human papillomavirus 
(HPV) infection.26 Reduced vulnerability to persistent HPV infection would make 
cervical cancer less likely to occur and perhaps transgender males on hormone 
therapy have a low risk of cervical cancer. However, some data supports the 
notion that inadequate tests in non-transgender females increases their likelihood 
of having abnormal pap tests in the future.28 This suggests that high rates of 
inadequate pap tests in transgender males may actually put them at higher risk of 
future cervical abnormalities.  
	19 
It is well-documented that transgender females and transgender males 
have experiences with the healthcare system and with healthcare providers that 
are different from those in the cisgender population. Transgender individuals 
struggle to find providers who deliver care specific to their needs and who are up 
to date on the applicable gender-based screenings. Finding a provider who 
welcomes transgender patients into their care and who can use gender-appropriate 
language is also difficult for this population. Transgender individuals often face 
discrimination in the form of negative reactions upon exposure of identity, 
harassment, and refusal of care. As such, it is important for healthcare 
professionals to have a background that covers transgender-specific needs and 
educates them on the appropriate language to use. Fostering a comfortable 
environment for transgender patients is especially important and, perhaps, this can 
be achieved by increasing provider knowledge and comfort in delivering care to 
this patient population. 
Existing research 
As of 2010, an average number of five hours was spent teaching LGBT 
related content throughout the entire curriculum at allopathic and osteopathic 
medical schools in the U.S. and Canada.7 This data was collected via internet 
questionnaires completed by the deans of medical education at 132 institutions. 
Five schools (3.8%) reported zero hours of education on this topic during 
classroom or clinical time and forty-four (33.3%) reported zero hours of LGBT 
teaching content in the clinical setting.7 Clinical sites with LGBT-focused care 
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were offered as electives at twelve schools (19.1%) and seven (5.3%) medical 
schools required students to have experience at an LGBT-focused clinical site.7 
Deans at 123 schools either reported that education on the difference between 
behavior and identity was not present or they did not know if it was covered in 
medical student education. Fewer than 40% of schools provided any information 
on sex reassignment surgery and gender transitioning during their curriculum.7 
Although this study does not explore the effectiveness of LGBT exposure during 
medical school in terms of student preparedness for clinical interactions, it does 
illustrate how much exposure to LGBT material, or lack thereof, is present during 
medical education.  
In 2010, an online questionnaire was also sent out to students at 176 
osteopathic and allopathic medical schools in the U.S. and Canada. Of the 4,262 
responses used in analysis, 67.3% of students rated their LGBT education as fair, 
poor, or very poor.8 Analysis of all responses revealed that students felt prepared 
to discuss sexually transmitted infections (STIs) and HIV at a higher rate than any 
other LGBT health concern.8 The majority of respondents did feel that they were 
more equipped to care for LGBT patients after receiving education in medical 
school. However, this again stresses the inaccuracy of grouping transgender care 
into the broader LGBT care. Even though nearly two thirds of students felt their 
education enhanced their preparedness to handle LGBT health, only 28% of 
respondents felt comfortable discussing gender transitioning.8 Although this study 
included a large sample size of 4,262, there were over 100,000 medical students 
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enrolled at the time the questionnaire was released and this small percentage 
might not truly reflect the views of medical students in the U.S. and Canada.  
 Students in this survey also responded that increased clinical experience 
with the LGBT population was the most important factor in improving LGBT 
health education in medical school.8 Assuming that all third-year medical students 
were in the midst of their clinical rotations, it would be expected that these 
students would feel more prepared than their second-year counterparts who were 
still completing their didactic training. 65.6% of third-year medical students felt a 
significant increase in their sense of preparedness to care for LGBT patients after 
their medical school training compared with 58.4% of second-year students. In 
fact, students in their third year of medical school had a greater sense of 
preparedness in almost every aspect of LGBT health compared to the second-year 
students.8 Although these reports were self-perceptions and may not represent true 
behaviors in practice, how a person views their own abilities can have a major 
impact on their actions. Thus, the researchers felt this was an important facet to 
measure.  
 In addition to the online questionnaire, thirty-five students from five 
different medical schools participated in a focus group. Reponses from many of 
the individuals continued to highlight that real-life interactions are the most 
helpful method to learn how to care for those who identify as LGBT. One 
participant related that students who are devoid of experiences with the LGBT 
population are, “not going to feel comfortable asking questions in a history or 
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asking more of those deep probing-type questions. And so if it weren’t for my 
own personal experiences, I probably wouldn’t feel prepared at all”.8 Other 
students discussed how their training on LGBT health did not always include 
strategies for follow-up counseling. One respondent gave an example of how 
educators teach students to ask their patients, “… ‘Do you have sex with men, 
women, or both?’ But then that’s all they really tell us, so I don’t know where to 
go from there, how to counsel a patient, what to say to not offend a patient…”.8 
The authors do speculate that students identifying as LGBT or those who have 
particular interest in LGBT health are likely to find more faults and judge their 
education in this field more harshly than the general medical student population.8 
Student Attitudes Toward Transgender Care 
In 2013, researchers at Boston University School of Medicine (BUSM) 
investigated how the attitudes of students regarding transgender care would 
change by adding a lecture on transgender health to the curriculum. Students at 
any stage in their medical education were sent an anonymous online survey that 
examined their attitudes and willingness to treat transgender patients. Students in 
their second year of medical school completed this survey one month prior to 
their educational course that covered transgender health and repeated the survey 
one month after the course. The transgender medicine portion of the course 
focused on gender identity, treatments for transgender individuals, and 
considerations in monitoring treatment.9 
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Prior to the course, 18% of students reported they would not be willing to 
see a FTM transgender patient and 15% would not be willing to see a MTF 
transgender patient.9 Prior to exposure of transgender-specific content in the 
course, 38% of students anticipated they would feel uncomfortable caring for 
FTM and MTF transgender patients.9 Surprisingly, MTF medicine and FTM 
medicine were not viewed as equal in terms of having a place in conventional 
medicine. Out of the seventy-four students surveyed, four reported that treatment 
of FTM patients was not part of conventional medicine and seven reported that 
treatment of MTF patients was not part of conventional medicine.9 The responses 
in the pre-course survey from second year students did not differ statistically from 
those in the first, third, and fourth years. In the post-course survey, only 2% of 
second year students would refuse to see a FTM or MTF patient for transgender 
care.9 After taking the course with transgender-specific content, the researchers 
noted a 63% drop in anticipated discomfort level when caring for a MTF 
transgender patient. Zero students believed that transgender care was not a part of 
conventional medicine in the post-course survey.9 It is of note that only seventy-
four second year students out of a total of 180 completed the pre-course survey 
and only sixty-six followed-up with the post-course survey. It is possible that 
there is a nonresponse bias within this study, meaning that students who were 
most uncomfortable with this topic chose not to participate. Thus, the survey 
results may overestimate the percentage of positive attitudes toward transgender 
healthcare among BUSM students. Additionally, this study was conducted in 
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Boston, a city known for having a liberal disposition, and at a school associated 
with Boston Medical Center, a liberal institution. These results may, thus, not be 
generalizable to other more conservative areas of the country.  
Current Providers and Transgender Healthcare 
It is estimated that there are 1.4 million transgender individuals living in 
the U.S., and this suggests a high likelihood that health care providers will interact 
with this population at some point in their career.13 All providers in every 
specialty should be exposed to transgender health education during medical 
school and beyond so that transgender patients may receive the care they deserve 
in both primary care and specialty care settings. In particular, understanding 
transgender health is of the utmost importance in the specialties of primary care, 
urology, OBGYN, oncology, endocrinology, and plastic surgery. Transgender 
patients may often initially present to their primary care providers for counseling, 
frequently receive hormone therapy from endocrinologists, may require gender 
based consults and treatment from oncologists, and will require the expertise of 
urologists, OBGYN providers, and plastic surgeons for gender-affirming 
surgeries.  
In a survey of 289 urology residents, 54% stated they had cared for 
transgender patients during their career.2 Rates of exposure varied by region of 
the country in which they practiced, with some rates as high as 74% in the 
Western part of the U.S.2 However, these numbers do not reflect how skilled these 
residents are in using appropriate language with transgender individuals nor do 
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they address the quantity of exposures these residents experienced. It was found 
that some residents who reported exposure to transgender patient care, in fact, 
were describing interactions with patients who had sexual development 
disorders.2 Although the ability to use culturally competent language in the realm 
of transgender care was not measured, it is clear that some residents did not have 
a strong understanding of transgender-appropriate terms within the medical 
language. 
Of the female urology residents who responded, 91% believed that 
gender-affirming surgical training was important and only 70% of male residents 
agreed with this.2 This mirrors results from a study looking at educational 
exposure to transgender patients among plastic surgery residents. Females placed 
higher importance on gender-affirming surgeries than their male counterparts 
(p<0.05).29 Neither of these studies included all residents in urology or plastic 
surgery in the U.S. and perhaps cannot be generalized to residents in every plastic 
surgery or urology residency program. However, responses from all major regions 
of the U.S. were recorded for both studies.  
In a survey of OBGYN providers at academic institutions across the U.S., 
more than 90% of providers stated they felt comfortable caring for individuals 
identifying as lesbian, gay, and bisexual.3 However, only 35.3% stated they would 
feel comfortable caring for MTF transgender patients and 29% stated they were 
comfortable treating FTM transgender patients.3 The vast majority of respondents 
did not know the eligibility requirements for transgender patients seeking gender-
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confirming surgeries. Over half of the 141 OBGYN providers who participated in 
this study did not know the recommendations for screenings of breast cancer, 
prostate cancer, hyperlipidemia, and diabetes in transgender females.3 Only 
88.7% reported willingness to perform a pap test on a transgender male and only 
80% would be willing to perform a breast exam on a transgender female.3 This 
data holds true in other fields of medicine, as shown in a survey of sixty-seven 
residents in primary care. Over 90% of those respondents felt as though they were 
not current on the screening guidelines for transgender men and transgender 
women.4  
Of the OGBYN respondents sampled in the above study, 113 stated they 
received no training regarding transgender health during residency.3 Given that 
the survey was only distributed to nine academic institutions in the U.S. and the 
majority of respondents were practicing in the Northeast and Midwest, these 
results may not be generalizable to other geographic areas in the U.S. 
Additionally, the authors note that only 141 out of 352 potential OBGYN 
participants responded to the survey. Those who chose not to participate may 
have either been uncomfortable with the topic of transgender health or may not 
interact with transgender patients regularly, concluding that the study did not 
concern their own practice.3 Had these individuals chosen to respond, perhaps the 
results would have shown even more compelling evidence that providers are 
unwilling, uncomfortable, and inexperienced in caring for transgender 
individuals. 
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In 2015, Irwig conducted a study on transgender healthcare delivery by 
distributing a survey to eighty practitioners at an endocrinology conference. The 
responses to the survey questions revealed that 42% of providers felt a similar or 
even increased comfort level in caring for transgender patients as compared with 
non-transgender patients.5 However, 73% reported they had seen four or fewer 
transgender patients in their career.5 Half reported little or no comfort in 
discussing sexual orientation or gender identity. Only 41% had self-perceived 
competency in providing care to transgender patients, and more than one third of 
the providers stated they would refuse to provide hormone therapy to transgender 
individuals.5 The perceived comfort level in caring for transgender patients is not 
reflected in the reported experience and perceived competency in transgender 
health. This discrepancy reveals the potential presence of response bias in this 
study. The author does note that 59% of endocrinology providers reported almost 
always using preferred gender pronouns with their patients.5 However, this still 
leaves transgender patients with a significant chance of being addressed 
inappropriately.   
Transgender individuals have expressed feelings of “exhaustion”, 
“nervousness”, and “hopelessness”, sensing that they are a target of common 
microaggressions such as misuse of pronouns.30 Within the transgender literature, 
microaggressions refer to subtle discriminatory behaviors or statements directed 
against individuals identifying as transgender.30 Experiencing microaggressions 
from providers in the context of gender identity is something that can be both 
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mentally and physically taxing for transgender patients and it may even deter 
them from seeking help from medical professionals. One individual who was 
particularly frustrated by the behavior of medical staff stated, “I haven’t been to a 
doctor since 2001. I go on WebMD. I go on the websites and see how to take care 
of myself”.30 
Those who identify as transgender may often present to their primary care 
provider before any other physician, looking for guidance and counseling as they 
navigate their identity in the world of medicine. However, in a survey of sixty-
seven primary care residents only 27% reported knowing where to refer a 
transgender patient to receive hormone therapy.4 This supports the idea that 
transgender patients regularly face barriers to care, beyond just negative personal 
interactions with providers. In this same survey of internal medicine residents 
working in primary care, nearly 97% believed that being well-informed on the 
medical needs of transgender individuals was important to their career.4 However, 
only 45% of individuals in this study had ever received education regarding 
healthcare for transgender patients.4 This lack of knowledge and background in 
transgender health can have damaging consequences for patients.  
During 2015-2016, Vance et al. conducted a research investigation and 
recruited twenty participants to serve in their study. The participants consisted of 
pediatric interns, psychiatry interns, fourth year medical students, and nurse 
practitioner students who were rotating in the Division of Adolescent and Young 
Adult Medicine at UCSF.31 Six online modules centered on transgender health 
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were administered to these participants and the online training was followed by a 
clinical observational experience in the pediatric gender clinic. Twenty topics 
pertaining to youth transgender health were assessed in the context of pre- and 
post-course status and participants were asked to rate their knowledge on these 
topics.31 Using a Likert scale, participants assessed their self-perceived 
knowledge in each area. Self-perceived awareness increased by at least one point 
in each of the twenty topics during this study.31 After their training, the 
participants rated the experience and usefulness of the modules and observational 
experience in eleven different questions. Every question received a mean rating of 
at least 4.4/5, with five being very satisfied.31 It is of note that this study was 
limited in its number of participants and its method of data collection. 
Additionally, UCSF is a liberal transgender-friendly institution and practitioners 
in other areas may not be as receptive to this topic of education. Nonetheless, 
these results show that a comprehensive course involving online learning, 
followed-up by clinical learning, is objectively helpful in improving self-
perceived awareness and knowledge in the area of transgender health. Although 
the participants in this study were only observing in the clinical setting, live 
interactions can be an instrumental experience for learners.  
Barriers to care for transgender individuals that continue to persist today 
include lack of knowledge among providers, little access to culturally competent 
care, and provider discomfort with transgender health. Providers in many 
specialties feel as though transgender health is important; however, many are not 
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equipped with the knowledge and language needed to carry out a positive 
healthcare visit for these patients. A primary care provider is generally the first 
professional a patient sees for non-emergent medical conditions and concerns. 
They are likely to see transgender patients in all phases of gender transitioning 
and, as such, they need to be prepared to counsel and treat these individuals at any 
stage. An educational seminar for current primary care providers, many of whom 
had little to no transgender health education in medical school, is a necessary 
element in their continued learning. In order to best serve their patients, providers 
must stay up to date on the evolving needs of each population. The proposed 
study will engage primary care providers in learning through a seminar and a 
hands-on interactive session. The information and experience provided to 
participants will likely increase their confidence and comfort in caring for 
transgender patients.  
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METHODS  
Study design 
This study will be a two-part educational evaluation. Part one will seek to 
compare attitudes, confidence, and comfort among current primary care providers 
regarding transgender patient care before and after an informative lecture. Part 
two will seek to compare their attitudes, confidence, and comfort in caring for 
transgender patients before and after a hands on clinical intervention. The study 
will include a statistical analysis of providers’ responses to survey questions in 
order to make these comparisons.  
Study population and sampling 
Subjects for this study will consist of current primary care providers, 
including physicians, nurse practitioners, and physician assistants, recruited from 
the Family Medicine department and Internal Medicine department at Boston 
Medical Center (BMC) – the affiliate hospital of Boston University School of 
Medicine. Participation will not be required but participants will have the option 
to receive continuing medical education (CME) credits with their involvement. 
There are currently 74 internal medicine providers and 42 family medicine 
providers at Boston Medical Center. The study author aims to recruit 70% of 
providers to establish a sample population that adequately represents providers in 
these specialties. The study author estimates that 80 subjects will be enrolled in 
this study. A sample size of 80 will be able to detect an effect size of 0.317 
standard deviations with an alpha of 0.05 and a power level of 80%.  
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Intervention 
The intervention will first begin with an educational seminar in 
transgender health. An expert in the field of transgender health will present one 
PowerPoint lecture of one-hour duration to the study participants. Table 1 outlines 
the topics and learning objectives that will be covered during the lecture.  
 
Table 1: Outline of Transgender Health PowerPoint Lecture  
Topic Learning Objective Duration 
1. Definitions of 
gender identity and 
sexual orientation  
2. Discussing gender 
identity and sexual 
orientation at 
healthcare visits. 
The learner will become 
familiar with 
approaching the topic of 
preferred name and 
pronouns with patients. 
 
10 minutes 
3. Medical and 
surgical gender-
affirming 
interventions and 
referrals for 
transgender 
patients. 
The learner will become 
knowledgeable about the 
different types of 
medical and surgical 
gender-affirming 
interventions for 
transgender patients. 
20 minutes 
4. Barriers to care 
faced by 
transgender 
females and 
transgender males. 
The learner will become 
knowledgeable about the 
barriers to transgender-
specific healthcare.  
15 minutes 
5. Health concerns 
within the 
transgender 
population. 
6. Appropriate cancer 
screenings based 
The learner will become 
knowledgeable about 
specific healthcare needs 
within the transgender 
population. 
15 minutes 
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upon the patient’s 
transgender 
identity. 
 
After the educational seminar, participants will then be asked to take part 
in a hands-on intervention in which they complete two mock healthcare visits 
with transgender patient actors. Table 2 outlines the OSCE scenarios. These 
individuals will be recruited from a pool of standardized OSCE patients. Each 
visit will allow providers the opportunity to use gender-appropriate language and 
will allow them to explore the ways in which they can foster a comfortable and 
welcoming environment for transgender patients. Actor patients will provide 
formative feedback to participants in between each visit. This feedback will be 
given using the Master Interview Rating Scale (MIRS).  
 
Table 2: Outline of OSCE Scenarios 
OSCE Session Scenario Duration  
Mock Visit with Actor 
Patient #1 
Transgender male patient 
who presents to clinic as 
a first-time patient 
seeking to establish a 
primary care provider. 
Study participant must 
take a complete medical 
history. * No physical 
exam required.  
15 minutes 
Feedback with Actor 
Patient #1 
Formative Feedback 
using MIRS 
5 minutes 
Mock visit with Actor 
Patient #2 
Transgender female 
patient who presents to 
clinic as a first-time 
15 minutes 
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patient seeking to 
establish a primary care 
provider. Study 
Participant must take a 
complete medical 
history. * No physical 
exam required.  
Feedback with Actor 
Patient #2 
Formative Feedback 
using MIRS 
5 minutes  
*Medical History includes past medical history, past surgical history, family 
history, and social history.  
 
Study variables and measures 
All participants will complete a demographic survey consisting of four 
questions (Appendix 1). Participants will also take a baseline survey consisting of 
fifteen items using a Likert scale of 1-5 (Appendix 2). This survey will be 
repeated following the PowerPoint lecture and once again following the OSCE 
session. All study variables are listed in Table 3. The fifteen items in the Likert 
scale survey are organized into three major outcome variables. Items 1-5 assess 
the importance providers place on their knowledge and abilities in the realm of 
transgender health, as well as the responsibility they feel in caring for this 
population. Thus, these items all assess attitudes held by providers. Items 6-7 
measure comfort in caring for transgender males and females. Lastly, items 8-15 
assess confidence in caring for transgender males and transgender females in four 
different areas that reflect the learning objectives from the PowerPoint 
presentation.  
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Table 3: Study Variables and Outcome Variables 
Demographic Survey Variables • Gender Identity 
• Professional Title  
• Duration of Experience as a 
Provider 
• Prior Experience with 
Transgender Patients 
Outcome Variables in Baseline 
Survey, Post-lecture survey, and 
Post-OSCE survey 
• Attitudes Toward Providing 
Care to Transgender Patients   
• Confidence in Providing Care 
to Transgender Patients 
• Comfort in Providing Care to 
Transgender Patients  
 
Recruitment 
Department heads in the Internal Medicine and Family Medicine 
departments at Boston Medical Center will send out an email to their respective 
teams inviting them to participate in this study. Emails will only be sent to 
physicians, nurse practitioners, and physician assistants. Participation by 
providers is not required but they will have the opportunity to receive CME 
credits for their participation. The email will include the topics being covered 
during the study as well as the dates and times during which the study will take 
place. The intervention will be offered on three separate dates to ensure an 
adequate number of participants.  
Data collection 
Upon arrival, all participants will receive a folder containing a packet. The 
packet will include the background survey (Appendix 1) and three copies of the 
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Likert scale survey (Appendix 2). Each copy of the Likert scale survey includes a 
space for participants to indicate whether they are completing the survey pre-
lecture, post-lecture, or post-OSCE sessions. Neither the folder nor packet will 
include any name identifiers.  After completing all four surveys, the participant 
will turn in their folder at the end of the day. All data from these surveys will be 
entered and stored into the secure software, Research Electronic Data Capture 
(REDCap) by a data entry clerk.  
Data analysis 
Data from the baseline Likert scale, post-lecture Likert scale, and post-
OSCE Likert scale will be subjected to separate analyses according to the time at 
which they were completed. Survey timeframes are outlined in Table 4 below. 
Table 4: Survey Timeframes  
Time Session Status Survey  
A Pre-Lecture (no 
intervention) 
Baseline Likert Scale 
Assessment 
B Post-Lecture/ Pre-OSCE Post-Lecture Likert 
Scale/ Pre-OSCE Likert 
Scale 
C Post-OSCE Post-OSCE Likert Scale 
 
Data from time A and time B will be analyzed using a Wilcoxon signed 
rank test for items 1-5 and 6-7 on the Likert Scale. Data from time B and time C 
will be analyzed using a Wilcoxon signed rank test for items 1-5 and 6-7 on the 
Likert scale. Items 1-5 and 6-7 will be analyzed separately as they assess two 
different outcomes. Items 1-5 pertain to attitudes and 6-7 pertain to comfort. Items 
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8-15 all assess confidence. Due to the larger number of items for this outcome 
variable, there will be a wider range of responses than those for attitudes and 
comfort. Confidence will be considered a normally distributed continuous 
variable that meets parametric assumptions. For items 8-15, a paired t-Test will be 
used to analyze data from times A and B, as well as B and C. 
Timeline and Resources 
	 The development of materials and recruitment of personnel for this study 
will begin in the winter of 2019. The expectation is to implement the study in the 
summer of 2020 and data analysis will commence in the fall of 2020. The budget 
will be allocated to administrative support, supplies, and to the expert lecturer and 
OSCE patient actors. Timeline and budget are described in tables 5 and 6 
respectively.  
 
Table 5: Study Timeline 
Timeline Tasks  
Winter 2019 • IRB submission and approval 
• Recruitment of standardized 
OSCE patient actors 
• Recruitment of lecturer for 
PowerPoint presentation and 
development of materials for 
PowerPoint 
Spring 2020 • Development of Demographic 
Survey 
• Development of Likert Scale 
Survey 
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Summer 2020 • Pre-intervention surveys 
• PowerPoint Presentation 
• Post-lecture survey 
• OSCE sessions 
• Post-OSCE survey 
• Study Completion 
Fall 2020 • Data Analysis  
• Manuscript to be submitted  
 
Table 6: Budget 
Allocation Tasks  
Administrative Support • Clerical  
• Data Entry 
• Statistical consulting  
Supplies • PowerPoint lecture 
Expert Lecturer • One hour-long presentation 
OSCE patient actors • 15-minute mock healthcare 
visit sessions + 5-minute 
feedback sessions 
 
Institutional Review Board 
The study will be submitted to the Boston University Medical Campus IRB for 
review under 45 CFR 46. 101 (b) criteria to qualify for exemption. This study 
qualifies for exemption under category 3 of section 10.2.4.2.1.2 of the Human 
Research Protection Program Policies. If the board does not approve the exempt 
status, the IRB protocol will be submitted for expedited review.  
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CONCLUSION 
Discussion 
This study focuses on acquisition of confidence and comfort among 
primary care providers as they participate in a two-part educational seminar on 
transgender health. This study is unique in that it recruits providers currently 
practicing and that the educational lecture is directly followed-up with hands-on 
experience. Importantly, this study allows for participants to familiarize 
themselves with interacting with transgender patients.  
Despite these strengths, there are limitations to this study. Beginning with 
the recruitment of participants, this study is not mandatory and CME credits may 
act as motivation to participate. It is possible that this will create a biased 
participant pool that consists of providers who are either most interested in 
transgender health or those with the sole objective of receiving CME credits. 
Alternatively, it may exclude participation by providers who are most 
uncomfortable with the topic of transgender health. Additionally, this study will 
recruit providers from BMC, a liberal institution with a center for transgender 
medicine and surgery. Providers in this study may have a sound background in 
transgender health, regardless of the educational content during their training, and 
thus, smaller changes in confidence and comfort may be observed throughout the 
study. This has the potential to minimize the impact of this intervention. 
Additionally, results of this study may not be generalizable to more conservative 
areas outside of Boston.  
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 Given that the PowerPoint lecture is limited to one-hour in duration, there 
is a restricted number of learning objectives incorporated into this section of the 
seminar. It is possible that areas of transgender health not covered in the lecture, 
or those that are inadequately addressed in the lecture, may result in insignificant 
improvement or stagnation of confidence and comfort in certain areas. In 
addition, confidence will be measured on a scale that includes eight different 
items, four of those pertaining to transgender males and four pertaining to 
transgender females. This design would allow for improvements in overall 
confidence to mask any absence of improvement in individual items.  
 There are weaknesses present within the OSCE portion as well. The 
standardized patients for these OSCE scenarios do not necessarily identify as 
transgender and may only have the ability to approximate the life of a transgender 
individual. There may be nuances to the transgender identity that these actors 
cannot fully express. Given that 80 providers are expected to participate in this 
study, there will be more than one standardized patient for each OSCE scenario. 
Although they are formally trained for their role, there may be subtle differences 
with each actor patient that can alter how participants perceive their confidence 
and comfort in completing a healthcare visit with a transgender patient. This also 
highlights that the measurement tool for this intervention relies on self-reports 
and, thus, there is potential for response bias. Additionally, all four surveys are 
given to participants at the start of the study and are not handed in until 
completion of the study. This strategy, although useful for keeping participants’ 
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responses grouped, will allow opportunity for subjects to change their answers to 
survey questions at any point in time. 
 Analyses beyond the scope of this study may include differences due to 
participants’ gender identity, their status as an MD, NP, or PA, and the presence 
or absence of interactions with transgender patients prior to this study. In the 
future, this seminar may be piloted or implemented at other medical institutions 
and may encourage more providers to continue to stay up-to-date on healthcare 
needs within the transgender population. Primary care providers across the nation 
should be equipped with the confidence and comfort to carry out successful 
healthcare visits with transgender patients.   
Summary 
Receiving care in a welcoming environment is a fundamental feature of 
healthcare visits sought by transgender patients. Given that many transgender 
patients present to a primary care provider before any other provider, it is 
particularly important that PCPs are able to succeed in creating this atmosphere. 
Many transgender patients experience discrimination in the form of refusal of 
care, harassment, or negative reactions upon gender identity disclosure, and often 
lack these desired safe places in which to obtain their care. The cause of this is 
likely multifactorial, including provider unfamiliarity with transgender 
individuals, provider discomfort with delivering care to transgender patients, and 
lack of knowledge pertaining to transgender healthcare among providers. Poor 
healthcare experiences can be taxing for transgender individuals and may lead to 
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missed appointments, delay of care, and unsafe, uninformed practices on the part 
of these transgender individuals. Improving these deficits in provider confidence 
and comfort is a difficult task given that many providers currently practicing have 
an inadequate background education in transgender healthcare.  
The proposed study combines an educational lecture by an expert in the 
field of transgender health with a hands-on clinical experience with transgender 
actor patients. The lecture contains learning objectives that cover transgender-
specific healthcare needs, as well as social aspects of transgender health, such as 
use of gender-appropriate language and barriers to care faced by transgender 
individuals. The hands on clinical experience offers current primary care 
providers the opportunity to conduct a complete history, gathering a 
comprehensive picture of the transgender patient. These mock healthcare visits 
also present an opportunity to use gender-appropriate terminology and allow 
participants to discover how they can best create a welcoming environment for 
transgender patients. The end goal of the study is to improve confidence and 
comfort among primary care providers in completing a healthcare visit with 
transgender patients.  
Clinical and/or public health significance 
All providers, similar to the patients they care for, have unique 
experiences, biases, and perceptions of the world. Regardless, they must become 
proficient in caring for all patients who seek care from them. Existing literature 
supports the notion that healthcare providers are uncomfortable and lack 
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confidence in caring for the transgender population. This research also highlights 
how comfort and self-perceived ability to care for transgender patients improves 
through medical school education, particularly with clinical experience. As a 
result, this two-part educational evaluation has been created with the aim of 
improving confidence and comfort among current primary care providers, who 
likely received their training during a time when there was little to no 
transgender-specific content. This educational experience could be adopted by 
medical institutions across the nation and may potentially be incorporated into 
training in other specialties outside of primary care. The desire is for transgender 
patients to receive their healthcare from knowledgeable and trusting providers.   
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APPENDIX 
 
APPENDIX 1 
Demographic Survey to be Completed Before Handing in Packet 
Question Answer 
Which gender do you identify with?  Male    Female    Gender- 
nonconforming 
What is your title? MD          NP          PA 
How many years have you been 
practicing as a provider?  
Please write your answer here:  
Have you ever provided care to a 
transgender patient?  
YES               NO 
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APPENDIX 2 
Survey for Pre-lecture, Post-lecture, and Post-OSCE 
Are you completing this survey pre-
lecture, post-lecture, or post-OSCE? 
Please write your answer here: 
 
 
Question Answer Choice 1= strongly 
disagree, 2 = disagree, 3 = neutral, 4 
= agree, 5 = strongly agree 
1. It is important to me to be 
knowledgeable in transgender 
health.  
 1       2       3       4       5 
2. It is important to me that I 
always use gender-appropriate 
language during healthcare 
visits. 
1       2       3       4       5 
3. It is important to me that 
transgender patients feel 
comfortable seeking care from 
me.  
1       2       3       4       5 
4. It is my responsibility to provide 
competent care to transgender 
female patients. 
1       2       3       4       5 
5. It is my responsibility to provide 
competent care to transgender 
male patients. 
1       2       3       4       5 
6. I feel comfortable completing a 
healthcare visit with a 
transgender female patient. 
1       2       3       4       5 
7. I feel comfortable completing a 
healthcare visit with a 
transgender male patient. 
1       2       3       4       5 
8. I am confident in my ability to 
use preferred names and 
pronouns with transgender 
female patients.  
1       2       3       4       5 
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9. I am confident in my ability to 
use preferred names and 
pronouns with transgender male 
patients.  
1       2       3       4       5 
10. I am confident in my ability to 
counsel transgender female 
patients regarding medical 
gender-affirming treatments. 
1       2       3       4       5 
11. I am confident in my ability to 
counsel transgender male 
patients regarding medical 
gender-affirming treatments. 
1       2       3       4       5 
12. I am confident in my ability to 
counsel transgender female 
patients regarding surgical 
gender-affirming treatments.  
1       2       3       4       5 
13. I am confident in my ability to 
counsel transgender male 
patients regarding surgical 
gender-affirming treatments.   
1       2       3       4       5 
14. I am confident in my ability to 
address transgender-specific 
healthcare needs with 
transgender female patients. 
1       2       3       4       5 
15. I am confident in my ability to 
address transgender-specific 
healthcare needs with 
transgender male patients. 
1       2       3       4       5 
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LIST OF JOURNAL ABBREVIATIONS 
	
Acad Emerg Med Academic Emergency Medicine 
Acad Med Academic Medicine 
Am J Public Health American Journal of Public Health 
Health Soc Work Health & Social Work 
JAMA The Journal of the American Medical Association 
J Adolesc Health Journal of Adolescent Health 
J Clin Pathol Journal of Clinical Pathology 
J Homosex Journal of Homosexuality 
Qual Health Res Qualitative Health Research  
Plast Reconstr Surg Plastic and Reconstructive Surgery 
Patient Educ Couns Patient Education and Counseling  
Teach Learn Med Teaching and Learning in Medicine  
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